Kiniksa Pharmaceuticals International Plc (KNSA)
53.39
-0.25
(-0.47%)
USD |
NASDAQ |
May 19, 16:00
53.39
0.00 (0.00%)
After-Hours: 17:53
Kiniksa Pharmaceuticals International Research and Development Expense (Quarterly) : 27.33M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 7.47M |
| Amgen, Inc. | 1.719B |
| BioMarin Pharmaceutical, Inc. | 178.80M |
| United Therapeutics Corp. | 138.20M |
| AbbVie, Inc. | 2.472B |